{"resourceType":"Observation","id":"cef2c785-ffef-561c-80a8-7a56df349ba6","meta":{"versionId":"1","lastUpdated":"2022-05-24T16:59:24.427-04:00","source":"#xvoEwsInfRYeSB5V","profile":["http://fhir.mimic.mit.edu/StructureDefinition/mimic-observation-micro-test"]},"identifier":[{"system":"http://fhir.mimic.mit.edu/identifier/observation-micro-test","value":"9862026-90134"}],"status":"final","category":[{"coding":[{"system":"http://terminology.hl7.org/CodeSystem/observation-category","code":"laboratory"}]}],"code":{"coding":[{"system":"http://fhir.mimic.mit.edu/CodeSystem/microbiology-test","code":"90134","display":"EPSTEIN-BARR VIRUS VCA-IgM AB"}]},"subject":{"reference":"Patient/91f25704-6153-5259-bdd7-2ca6478de14a"},"encounter":{"reference":"Encounter/a4a4cd40-69d3-5eaf-b165-861cc5092684"},"effectiveDateTime":"2153-03-29T04:08:00-04:00","valueString":"NEGATIVE <1:10 BY IFA.  INTERPRETATION: RESULTS INDICATIVE OF PAST EBV INFECTION.  In most populations, 90% of adults have been infected at sometime with EBV and will have measurable VCA IgG and EBNA antibodies. Antibodies to EBNA develop 6-8 weeks after primary infection and remain present for life. Presence of VCA IgM antibodies indicates recent primary infection.  ","specimen":{"reference":"Specimen/d0738fe5-9bb4-5f5a-9d21-b907067a26db"}}